Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.
Kaneda-Nakashima K, Shirakami Y, Hisada K, Feng S, Kadonaga Y, Ooe K, Watabe T, Manabe Y, Shimoyama A, Murakami M, Toyoshima A, Haba H, Kanai Y, Fukase K.
Kaneda-Nakashima K, et al. Among authors: feng s.
Int J Mol Sci. 2024 Nov 18;25(22):12386. doi: 10.3390/ijms252212386.
Int J Mol Sci. 2024.
PMID: 39596451
Free PMC article.